Innova Captab Ltd
Innova Captab Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
4 of 4 strong
The short version
Innova Captab expects to deliver over 20% volume growth year-on-year, maintaining this growth trajectory in upcoming quarters. The company expects to maintain 20%+ volume growth in the coming periods, with an overall sales growth target of 20%+ for FY27.
From Innova Captab Ltd's Q1 FY27 earnings-call transcript · updated 9 Sept 2026.
Revenue & Sales Performance
- Innova Captab expects to deliver over 20% volume growth year-on-year, maintaining this growth trajectory in upcoming quarters.
- The guidance is approximately 20%+ volume growth for the full fiscal year FY27.
- Growth is driven by ramp-up at the Jammu plant, expanding product portfolio, onboarding new customers and geographies, and deeper engagement with existing customers.
- The Jammu facility, currently at 25-30% utilization, is projected to ramp up steadily, aiming to cross INR1,000 crores revenue.
- The company aims for 20%+ sales growth, combining volume growth and favorable pricing/product mix.
2 more points from Innova Captab Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Innova Captab Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Annual Capex Guidance for FY27 and FY28:
- Maintenance capex: INR 20-25 crores annually.
- Growth capex (existing capability augmentation/de-bottlenecking): INR 20-30 crores annually.
- Nature of Growth Capex:
- Mainly focused on internal debottlenecking, equipment replacement, and capacity doubling within existing plants.
- Greenfield/Big Expansion Projects:
- Any future large greenfield or new category expansion will be communicated to the market.
- Current large capex like Jammu (around INR 500 crores) already done; future expansions expected to be in smaller tranches (~INR 200-250 crores).
- Baddi Plant Capex Update:
- New plot acquisition done; plans are in progress and will be firmed up before public disclosure.
2 more points from Innova Captab Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Innova Captab Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Innova Captab Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Innova Captab Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹448 Cr, net profit ₹38 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Innova Captab's management said in earlier quarters
Others in Pharmaceuticals & Biotechnology this season
- Sanjivani Paranteral Ltd (Q1 FY27)
Q1 FY27 consolidated revenue from operations: ₹238.39 Mn, up 33.8% YoY from ₹178.92 Mn in Q1 FY26 (Page 25). Key investor presentation takeaways from Sanjivani
- Symbiotec Pharma (Q1 FY27)
Q1 FY27 consolidated revenue from operations: ₹218.2 crores, up 7% YoY from ₹203.2 crores in Q1 FY26 (Page 9). Key concall takeaways from Symbiotec Pharmalab…
- Jubilant Pharmova Ltd (Q1 FY27)
2,229 Cr., up 17% YoY (Page 97) . Key concall takeaways from Jubilant Pharmova Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Beta Drugs Ltd (Q1 FY27)
Q1-FY27 revenue from operations: INR 1,255 Mn, up 25.2% YoY from INR 1,002 Mn in Q1-FY26 (Page 32). Key concall takeaways from Beta Drugs Ltd's Q1 FY27…
Arthneeti Pro · Annual
Innova Captab Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Innova Captab Ltd Q1 FY27 results?
Innova Captab expects to deliver over 20% volume growth year-on-year, maintaining this growth trajectory in upcoming quarters. The company expects to maintain 20%+ volume growth in the coming periods, with an overall sales growth target of 20%+ for FY27.
What is Innova Captab Ltd share price analysis?
Innova Captab Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 43.7 with a market cap of ₹6,726 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innova Captab Ltd planning capital expenditure?
Annual Capex Guidance for FY27 and FY28: - Maintenance capex: INR 20-25 crores annually.
Keep Innova Captab Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.